Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders, Part 2

Breast Cancer Update ›

58:54 | Nov 29th

Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer.&...Show More